Arbutus Biopharma Corp. buy Lutz69
Start price
03.04.23
/
50%
€2.80
Target price
03.04.27
-
Performance (%)
-12.14%
End price
11.03.24
€2.46
Summary
This prediction ended on 11.03.24 with a price of €2.46. The price of Arbutus Biopharma Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -12.14%. Lutz69 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Arbutus Biopharma Corp. | -0.113% | -0.113% | 93.326% |
iShares Core DAX® | -1.471% | 1.895% | 25.178% |
iShares Nasdaq 100 | -0.486% | 4.395% | 29.415% |
iShares Nikkei 225® | -2.115% | 2.450% | 20.561% |
iShares S&P 500 | 0.394% | 3.118% | 29.456% |
According to Lutz69 what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by Lutz69 for this prediction
In the thread Arbutus Biopharma Corp. diskutieren
Buy Arbutus Biopharma Corp.
Stopped prediction by Lutz69 for Arbutus Biopharma Corp.
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.79
20.09.21
20.09.21
-
20.09.25
20.09.25
-26.16%
03.04.23
03.04.23
Could be worthwhile Investment >10% per year